Interferon-free treatment combo looks promising for HCV GT2, GT3 infectionNovember 18, 2015GastroenterologyInfectious Diseases
VIDEO: 12-week HCV retreatment effective if short course failsNovember 18, 2015GastroenterologyInfectious Diseases
Senate panel targets drug prices during FDA commissioner nomination hearingNovember 17, 2015Business of Medicine
Sofosbuvir/R yields benefits in compassionate use HCV programNovember 17, 2015Infectious DiseasesGastroenterology
CTAD: New aducanumab subanalysis bolsters phase III trials in very mild Alzheimer’sNovember 17, 2015Alzheimer's & CognitionGeriatricsNeurology
CTAD: Sigma-1 receptor agonist passes muster in small Alzheimer’s trialNovember 17, 2015Alzheimer's & CognitionGeriatricsNeurology
VIDEO: Longer HCV therapy worked even after short-term failuresNovember 17, 2015GeriatricsGastroenterologyInfectious Diseases
Multitargeted drug combination promising when new HCV antivirals failNovember 17, 2015Infectious DiseasesGastroenterology
AAP: Marijuana is harmful, addictive, and on the riseNovember 17, 2015Mental HealthAddiction MedicineAdolescent Medicine
